Clinical Trial Update: Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration [Phase 1]

View source ↗

Summary

The update reports the completion of a Phase 1 safety study of a topical treatment for dry age-related macular degeneration. The sponsor is MacuCLEAR, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Topical treatment for dry age-related macular degeneration

Snippet

Sponsor: MacuCLEAR, Inc. | Conditions: Nonexudative Age-related Macular Degeneration | Phase 1 | Status: COMPLETED